K2 Medical Research and TPG Establish Partnership to Build a Leading Integrated Site Platform
TPG Inc. - Class A (TPG)
Company Research
Source: Business Wire
SAN FRANCISCO & ORLANDO, Fla.--(BUSINESS WIRE)--TPG (NASDAQ: TPG), a leading global alternative asset management firm, today announced a significant strategic growth investment in K2 Medical Research (“K2” or the “Company”), an integrated clinical trial site platform specializing in central nervous system (CNS) trials for leading pharma and biotech sponsors. TPG is partnering with K2’s management team to continue building a world class research platform. Terms were not disclosed.Founded by Chief Executive Officer, Sean Stanton, and Chief Medical Officer, Brandon Lenox, DO, K2 operates several de novo clinical trial sites across Florida. The Company specializes in conducting multi-phase clinical trials in complex therapeutic areas including Alzheimer’s, psychiatry, and liver disease (MASH), among others. K2’s model is centered around strong site operators, and the Company has successfully differentiated itself by developing direct relationships with pharma and biotech sponsors, whi
Show less
Read more
Impact Snapshot
Event Time:
TPG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TPG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TPG alerts
High impacting TPG Inc. - Class A news events
Weekly update
A roundup of the hottest topics
TPG
News
- Homrich Berg Announces New Minority Investment Partner TPG GrowthBusiness Wire
- India's First AI Unicorn Fractal Said to Weigh $500 Million IPO [Yahoo! Finance]Yahoo! Finance
- TPG Angelo Gordon, Dream Unlimited Corp., and Stadium Capital Partners to Acquire Dutch Residential Real Estate PortfolioBusiness Wire
- Ares Is Said in Advanced Talks on Deal With GLP Capital Partners [Yahoo! Finance]Yahoo! Finance
- TPG Inc. (NASDAQ: TPG) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $53.00 to $60.00. They now have a "buy" rating on the stock.MarketBeat
TPG
Earnings
- 8/6/24 - Beat
TPG
Sec Filings
- 9/13/24 - Form S-3ASR
- 8/6/24 - Form 10-Q
- 8/6/24 - Form 8-K
- TPG's page on the SEC website